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Background and purpose   Over the past 20 years, several changes 
in  treatment  policy  and  treatment  options  have  taken  place 
regarding hip replacement. For this reason, we wanted to inves-
tigate the results after hip replacement in terms of revision rate, 
during a 21-year period among hip replacements reported to the 
Norwegian Arthroplasty Register.
Methods      110,882  primary  total  hip  replacements  were 
reported  to  the  Norwegian  Arthroplasty  Register  from  1987 
through 2007. Risk of revision during the time periods 1993–1997, 
1998–2002, and 2003–2007 was compared to that of the reference 
period 1987–1992. Adjusted Cox regression analyses were per-
formed to compare the risk of revision in different time periods 
and extended analyses were done to investigate revision within the 
first postoperative year and after the first year. 
Results   There was an overall reduced risk of revision in the 
time  periods  1993–1997,  1998–2002,  and  2003–2007  compared 
to the reference period: RR = 0.81 (95% CI 0.77–0.86), 0.51 (CI 
0.47–0.55), and 0.77 (CI 0.68–0.85), respectively. The improved 
results were due to a marked reduction in aseptic loosening of 
the femoral and acetabular components in all time periods and 
in all subgroups of prostheses. A change in the timing of revision 
took place, with more early revisions and fewer late revisions in 
the later time periods. Revision due to dislocation and infection 
increased over time. 
Interpretation   The risk of revision decreased during the study 
period, due to fewer cases of aseptic loosening of prosthetic com-
ponents. The best results were obtained with the use of cemented 
prostheses. Prevention of dislocation and infection should be a 
major goal in the future, as revision due to these causes increased 
during the study period. 
 
The use of hip arthroplasty surgery has increased with time 
(Ingvarsson et al. 1999, Wells et al. 2002, Pedersen et al. 2005) 
as the population ages and patients with more comorbidity and 
of older age are accepted for surgery. The need for surveillance 
of long-term results was recognized early, leading to the estab-
lishment of national registries. The Swedish Hip Arthroplasty 
Register  was  established  in  1979,  followed  by  the  Finnish 
equivalent in 1980, and the Norwegian equivalent in 1987. 
In one recent publication on trends in primary hip arthroplasty 
in the USA from 1990 to 2004, an overall decrease in proce-
dure-related complications and adverse diagnoses was seen, 
although at the same time an increase in the prevalence of 
comorbidities took place (Liu et al. 2008). Herberts and Mal-
chau found a decrease in revision with time in the Swedish 
population after hip arthroplasty (Herberts and Malchau 1997). 
We evaluated the results of hip arthroplasty, with particular 
focus on time trends, during the period 1987 through 2007. 
Overall revision and also revision due to specific causes such 
as loosening of components, dislocation, or infection were 
studied. We also studied the timing of an event in relation to 
the primary operation for given causes of revision, and com-
pared 4 time periods. 
Patients and methods
We  used  data  from  the  Norwegian  Arthroplasty  Register 
(NAR),  which  is  a  population-based  prospective  database 
(Havelin et al. 2000). All hospitals in Norway at which the 
procedure is performed (n = 64 in 2007) report to the NAR. 
Data concerning patient identification, diagnosis, date of sur-
gery, whether the operation was primary or a revision, type 
of prosthesis, whether cement was used and type of cement, 
and the use of antibiotics, is derived from a form filled in by 
the operating surgeon (Furnes et al. 2002). Furthermore, the 
causes of revision and the procedures performed at revision 
are reported. In a study from 2006 comparing data from the 
NAR to the official patient administration system, the data in 
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In the present article these data were used to study changes 
in the rate of revision arthroplasty after primary surgery, over 
a 21-year period from 1987 through 2007. The patients were 
divided into four groups according to the year of primary sur-
gery: 1987–1992, 1993–1997, 1998–2002, and 2003–2007. 
The first period, from 1987 through 1992, was used as the ref-
erence period. 
From 1987 through 2007, 110,882 primary total hip replace-
ments were reported to the NAR (Table 1). For the analyses, 
patients  were  defined  as  having  osteoarthritis  (OA)  or  not 
(patients  with  all  other  diagnoses),  and  the  analyses  were 
adjusted for diagnosis, sex, and age.
During the study period, 99 different femur implants, 85 
different acetabular implants, and 70 different caput implants 
were used in Norway (Table 2). The 45 most common implant 
types  used  during  the  study  period  were  published  in  the 
annual  report  from  the  NAR  (http://www.haukeland.no/nrl/
eng/,  2008). The  Charnley  prosthesis  (DePuy,  Leeds,  UK) 
was the most common implant during the study period and the 
original monoblock Charnley prosthesis was used throughout 
the study period. 
In  prostheses  with  a  cemented  femoral  component,  the 
caput was modular in 52,371 cases while in 46,447 cases a 
monoblock femoral component was used. Of the uncemented 
Table 1. Age, sex, and diagnosis at primary surgery in 4 time periods 
  All  1987–1992  1993–1997  1998–2002  2003–2007
  n (%)  n (%)  n (%)  n (%)  n (%)
Mean age  69  69  70  70  70
Sex (% women)  70  70  70  70  69
n    110,882  24,651  24,659  28,817  32,755
Diagnosis         
    Osteoarthritis    79,700 (72)  16,597 (67)  17,130 (70)  20,976 (73)  24,997 (76)
   Rheumatoid arthritis      3,465 (3.1)       942 (3.8)       902 (3.7)       851 (3.0)       770 (2.4)
    Sequelae after fracture    11,933 (11)    3,299 (13)    3,133 (13)    2,886 (10)    2,615 (8)
    Sequelae dysplasia      8,125 (7.3)    2,037 (8.3)    1,795 (7.3)    2,032 (7.1)    2,261 (6.9)
    Sequelae dysplasia, 
    total luxation         879 (0.8)       414 (1.7)       214 (0.9)       141 (0.5)       110 (0.3)
  Sequelae Perthes’/epiphysiolysis      1,442 (1.3)       319 (1.3)       329 (1.3)       388 (1.3)       406 (1.2)
  Ankylosing spondylitis         477 (0.4)       105 (0.4)       116 (0.5)       144 (0.5)       112 (0.3)
  Acute fracture         969 (0.9)         55 (0.2)       116 (0.5)       233 (0.8)       565 (1.7)
Table 2. The most commonly used implants, in 4 time periods
 
Most commonly used  1987–1992  1993–1997  1998–2002  2003 and later  Total
a. Acetabular implants
  Charnley (DePuy)  11,947  11,789  10,431  7,270  41,437
  Exeter (Stryker)  2,609  2,029  2,866  3,871  11,375
  Reflection (Smith & Nephew)  0  818  3,505  6,613  10,936
  Titan (DePuy)  1,903  2,262  1,861  1,884  7,910
  Elite (DePuy)  597  409  1,261  2,950  5,217
  Tropic (DePuy)  1,065  1,443  1,232  82  3,822
  Spectron (Smith & Nephew)  2,128  1,117  406  0  3,651
  Trilogy (Zimmer)  0  381  1,012  1,517  2,910
  SP (Link)  474  393  776  1,211  2,854
b. Femoral implants
  Charnley (DePuy)  12,556  12,291  10,039  6,323  41,209
  Exeter (Stryker)  2,652  2,090  3,163  6,304  14,209
  Titan (DePuy)  2,669  2,776  3,069  2,913  11,427
  Corail (DePuy)  1,096  2,232  2,107  3,392  8,827
  Spectron (Smith & Nephew)  51  183  2,552  5,971  8,757
  ITH (Smith & Nephew)  1,230  1,446  983  64  3,723
  SP (Link)  1  394  582  1,128  2,105
c. Caput implants
  Exeter (Stryker)  2,269  2,088  3,206  6,598  14,161
  Universal (Smith & Nephew)  1,652  2,475  3,705  5,898  13,730
  Landos (Ortho Medic)  3,824  5,037  2,527  2,566  13,954
  Fjord (Ortho Medic)  0  392  2,841  3,431  6,664
  SP II Lubinus (Link)  0  388  584  1130  2,102Acta Orthopaedica 2010; 81 (6): 649–659  651
femoral components, 22,412 modular caput components were 
used as opposed to only 67 monoblocks. 
A prosthesis in which a cemented femoral component and 
an uncemented acetabular component was used was defined 
as a hybrid prosthesis, while inverse hybrid was the term used 
for a prosthesis with an uncemented femoral component and 
a cemented acetabular component. 23 different cement types 
were  used.  These  included  several  variants  of  the  Palacos 
(Heraeus Medical, Germany; Schering-Plough; Biomet) and 
Simplex (Howmedica, UK; Stryker) cements, which, for the 
purposes of this article, are analyzed together. 
A revision was defined as the removal or exchange of a part 
of or the whole implant. On the forms, several causes of revi-
sion could be given for the same patient. However, in the pres-
ent study only one cause was selected for each patient. This 
was done by a fixed system of priority; for instance, deep infec-
tion was selected when it was one of many causes, and pain 
was only selected when it was the only given cause of revision. 
Overall revision was defined as revision for any cause. 
Statistics
Information on death or emigration was obtained from Statis-
tics Norway. The patients were followed until time of revision, 
death, or emigration, or until the end of the study (December 
31, 2007), at which point the patients were censored. 
Analyses of overall revision (revision for any cause) were 
done for all prostheses together and separately for cemented, 
hybrid, inverse hybrid, and uncemented prostheses. A rather 
homogenous group of patients (n = 28,225) with a Charnley 
prosthesis cemented with Simplex or Palacos cements was 
selected in order to investigate possible changes that could 
not be attributed to changes in implant or cement type. Sepa-
rate analyses were performed for this group, as well as for 
a group of all other cemented implants. Charnley prostheses 
and Palacos and Simplex cements were chosen since they are 
well documented and have shown good results (Kavanagh et 
al. 1989, Schulte et al. 1993, Havelin et al. 1995, Furnes et al. 
1997, Espehaug et al. 2002, 2009). 
Kaplan-Meier survival plots were used to compare cumu-
lative prosthesis survival between subgroups of patients (i.e. 
patients operated during the 4 time periods). The overall risk 
of revision and the risk of revision due to specific causes (deep 
infection, dislocation, or aseptic loosening of the femoral or 
acetabular component) were calculated using Cox regression 
analyses. The risk estimates were adjusted for age, sex, and 
diagnosis. Based on figures for scaled Schoenfeld residuals 
showing an increased relative risk during the first postopera-
tive year, Cox analyses with time-dependent covariates, with 
indicators before/after the first postoperative year, were per-
formed. Thus, risk of revision within the first year was com-
pared between the different time periods using Cox regression 
analysis with time-dependent covariates, as was the risk of 
revision after the first year (Table 5). All analyses were per-
formed using SPSS software version 17.0.
Results
During the 21-year period, the sex distribution and mean age 
of the patients remained largely unchanged (Table 1). Sub-
analyses of age within the group of patients with osteoarthritis 
showed that the mean age remained the same during the 4 time 
periods, but the age distribution broadened, with more younger 
and more older patients operated during the later periods. The 
cause  of  arthroplasty  changed  towards  more  patients  with 
osteoarthritis and fewer with rheumatoid arthritis and sequelae 
after fracture (Table 1). Furthermore, there was a change in the 
types of implant used during the study period, with a decrease 
in Charnley prostheses in parallel with an increase in the use 
of Exeter and Spectron femoral components and Reflection 
cups being the most prominent changes (Table 2a and b). The 
use of modular caput implants increased in general, and for all 
the common implant brands (Table 2c). No marked change in 
the use of cemented versus uncemented prostheses occurred, 
although there was an increase in the use of inverse hybrid 
prostheses (with cementation of the acetabular component) 
(Table 3). The use of the high-viscosity cements Simplex and 
Palacos—and also cements closely resembling Palacos (Refo-
bacin bone cement R)—increased throughout the study period 
(Figure 1).
The major cause of revision was aseptic loosening of one or 
both implant components, seen in 5,328 cases and constituting 
Table 3. Fixation method for 4 time periods
  1987–1992  1993–1997  1998–2002  2003 and later   Total
  n (%)  n (%)  n (%)  n (%)  n (%) 
Cemented  19,837 (82)  19,833 (81)  23,161 (81)  24,104 (75)  86,935 (79)
Uncemented    3,142 (13)    3,355 (14)    3,715 (13)    4,410 (14)  14,622 (13)
Hybrid b    1,028 (4.3)    1,317 (5.4)    1,363 (4.7)       684 (2.1)    4,392 (4.0)
Inverse hybrid c         60 (0.2)         45 (0.2)       482 (1.7)    3,140 (9.7)    3,727 (3.4)
Total  24,067 (100)  24,550 (100)  28,721 (100)  32,338 (100)  109,676 (100) a
a The fixation method was not reported for 1,206 prostheses.
b Hybrid means cemented femur component and uncemented cup. 
c Inverse hybrid means uncemented femur component and cemented cup. 652  Acta Orthopaedica 2010; 81 (6): 649–659
66% of all revision operations (Table 4). Other major causes 
of revision were dislocation, infection, and pain, constituting 
14.5, 8.7, and 8.3 per cent (2.2 with pain as the only cause) of 
the revisions, respectively (Table 4). A decline in the number 
of revisions took place throughout the study period, for all 
causes of revision except dislocation and infection (Figure 2).
When considering overall revision (i.e. for any cause) for all 
types of hip implants together, the risk of revision for patients 
operated  during  the  second,  third,  and  fourth  time  periods 
was lower than for those operated during the reference period 
(Figure 3a) (RR = 0.51 (95% CI: 0.47–0.55) for 1998–2002 
compared to 1987–1992). Early revision, i.e. revision within 
the first postoperative year, was more frequent in the 3 later 
time periods (p < 0.001), while the opposite was seen for revi-
sions that took place after the first year (p < 0.001) (Table 
5a, first column). This indicates that although the revision rate 
was falling, revision surgery took place more rapidly after the 
primary operation in the later periods. 
Still considering all types of hip implants, the reduction in 
revisions was due to a statistically significant fall in revisions 
caused by acetabular or femoral component loosening (Table 
5a, second and third columns). For these 2 major causes of 
revision, no increase in revision within the first postoperative 
year was seen. The trend was opposite when considering revi-
sion due to dislocation, with an overall increase in revisions 
due to dislocation throughout the study period, with a greater 
increase in procedures taking place within the first postopera-
tive year, but also after the first year (Table 5a, column 4). A 
Figure 2. Numbers of revisions for different causes, in 4 time periods. Figure 1. Number of hips inserted using Simplex, Palacos, or cement 
types resembling Palacos (green), in 4 time periods. Blue represents 
other cement types. 
Table 4. Numbers of revisions due to specific causes for the 4 time periods
Cause of revision  All  1987–1992  1993–1997  1998–2002  2003–2007
Loose femur a  3,522  1,936  1,175     325      86
Loose acetabulum a  3,043  1,789     868     313      73
Aseptic loosening b  5,328   2,984   1,681      526      137 
Dislocation  1,177     258      333      338      248 
Infection     706     160      175      168      203 
Fracture     392     164     123      62      43
Pain     668 (175 e)     319     220      91      38
Osteolysis acetabulum c     266     130     109      23       4
Osteolysis femur c     301     163     109      26       3
Total d  8,094  3,806  2,504  1,125    659
a Aseptic loosening of one component.
b Aseptic loosening of one or both components.
c Osteolysis without loosening.
d More than one cause of revision may be reported; thus, the sum of the different causes does not 
  equal the total number of revision procedures.
e In 175 patients, pain was the only reported cause of revision.Acta Orthopaedica 2010; 81 (6): 649–659  653
similar trend was seen for revisions due to infection, although 
it was less evident—except for the period 2003–2007 (Table 
5a, column 5).
When  analyzing  all  cemented  prostheses  separately,  the 
results were very much the same as for all prostheses analyzed 
together, with an improved overall revision rate (Figure 3b) 
and particularly less revisions due to aseptic loosening (Table 
5b, columns 1, 2, and 3). As was seen in the total group, there 
were more early revisions and less late revisions during the 
last 3 time periods. The risk of revision due to dislocation 
increased during the 3 later time periods, particularly revi-
sion procedures performed within the first postoperative year 
(Table  5b,  column  4).  Furthermore,  revisions  due  to  deep 
infection increased, as was seen for the total group (Table 5b, 
column 5). 
Patients with cemented Charnley prostheses (with Palacos 
or Simplex cement) had a better overall survival compared 
to those with uncemented, hybrid, inverse hybrid, and non-
Charnley cemented prostheses (p < 0.001) ( Figure 4a), a find-
ing that was less prominent but still present during the last 
10-year period (p<0.001) (Figure 4b). In the 1,206 patients for 
whom the fixation method was unknown, the results closely 
resembled those of the hybride group (not included in Figure 
4). In the adjusted analysis, overall revision rate for the Charn-
ley group increased during the second period compared to the 
first, while a statistically significant decrease in revision was 
seen in the third period, with a similar trend during the fourth 
one (Table 5c, column 1). Revisions performed within the first 
year were more common during all the 3 later periods, while 
the opposite was seen for revisions after the first year (except 
in the second time period). 
When  considering  revision  due  to  aseptic  loosening,  the 
risk of revision within the first postoperative year remained 
unchanged throughout the study period, while a reduction in 
such revisions performed after the first postoperative year was 
seen after 1997 (Table 5c, columns 2 and 3). As for the total 
group, the risk of revision due to dislocation increased during 
the study period, but no significant change in the risk of revi-
sion due to deep infection was seen except for an increased 
risk in the period from 2003 through 2007 (Table 5c, columns 
4 and 5). 
The results after insertion of cemented prostheses other than 
Charnley were similar to those described for the total study 
group (Table 5d). 
Uncemented prostheses (n = 14,621) generally had a worse 
prognosis than the cemented ones (Figure 4a), but the results 
improved with time and the gap between cemented and unce-
mented implants narrowed (Figure 4b). The regression analy-
Figure 3. Kaplan-Meier survival plots. Revision for any cause in 4 time periods. A. All prostheses. B. All cemented 
prostheses. C. All uncemented prostheses. D. All hybrid prostheses. 
A
C
B
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Table 5a. Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral com-
ponent, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). All prostheses, n = 101,550
  A  B  C  D  E  F
Total 
  1987–1992  1    1    1    1    1
  1993–1997  0.81  <0.001  0.69  <0.001  0.67  <0.001  1.58  <0.001  1.18  0.2
    (0.77–0.86)    (0.63–0.75)    (0.62–0.72)    (1.32–1.90)    (0.94–1.47) 
  1998–2002  0.51  <0.001  0.43  <0.001  0.23  <0.001  1.87  <0.001  1.11  0.4
    (0.47–0.55)    (0.37–0.49)    (0.20–0.26)    (1.56–2.26)    (0.88–1.40)
  2003–2007  0.77  <0.001  0.36  <0.001  0.19  <0.001  2.21  <0.001  2.13  <0.001
    (0.68–0.85)    (0.28–0.47)    (0.15–0.24)    (1.80–2.72)    (1.69–2.68)
First year 
  1987–1992  1    1    1    1    1
  1993–1997  1.48   <0.001  1.02  1.0  0.83  0.4  2.22  <0.001  1.99  0.01
    (1.19–1.84)    (0.59–1.75)    (0.54–1.27)    (1.56–3.16)    (1.17–3.41)
  1998–2002  1.64  <0.001  0.89  0.7  0.37  <0.001  2.81  <0.001  2.05  0.007
    (1.33–2.03)     (0.52–1.54)    (0.22–0.63)    (2.01–3.93)    (1.21–3.46)
  2003–2007  2.09  <0.001  0.51  0.04  0.37  <0.001  2.88  <0.001  4.60  <0.001
    (1.71–2.56)    (0.27–0.98)    (0.22–0.63)    (2.06–4.03)    (2.85–7.41)
After 1 year
  1987–1992  1    1    1    1    1
  1993–1997  0.78  <0.001  0.68  <0.001  0.66  <0.001  1.39  0.002  1.04  0.8
    (0.74–0.83)    (0.63–0.75)    (0.61–0.72)    (1.13–1.72)    (0.80–1.33)
  1998–2002  0.42  <0.001  0.41  <0.001  0.22  <0.001  1.51  <0.001  0.93  0.6
    (0.39–0.46)    (0.36–0.47)    (0.19–0.25)    (1.20–1.91)    (0.71–1.22)
  2003–2007  0.54  <0.001  0.36  <0.001  0.17  <0.001  2.09  <0.001  1.44  0.02
    (0.47–0.62)    (0.27–0.48)    (0.13–0.22)    (1.55–2.83)    (1.06–1.94)
 
A  Time period  
B  All revisions RR (95% CI) and p–value 
C  Acetabular loosening RR (95% CI) and p–value
D  Femoral loosening RR (95% CI) and p–value
E  Dislocation RR (95% CI) and p–value
F  Infection RR (95% CI) and p–value       
Table 5b. Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral com-
ponent, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). All cemented prostheses, n = 86,929
  A  B  C  D  E  F
Total   
  1987–1992  1    1    1    1    1
  1993–1997  0.92  0.01  0.87  0.012  0.81  <0.001  1.57  <0.001  1.17  0.2
    (0.86–0.98)    (0.78–0.97)    (0.75–0.88)    (1.28–1.92)    (0.91–1.49)
  1998–2002  0.59  <0.001  0.64  <0.001  0.25  <0.001  2.01  <0.001  1.07  0.6
    (0.54–0.64)    (0.55–0.74)    (0.22–0.29)    (1.63–2.47)    (0.83–1.37)
  2003–2007  0.72  <0.001  0.40  <0.001  0.17  <0.001  2.20  <0.001  1.82  <0.001
    (0.65–0.81)    (0.30–0.54)    (0.13–0.22)    (1.74–2.77)    (1.41–2.34)
First year 
  1987–1992  1    1    1    1    1
  1993–1997  1.72   <0.001  1.00  1.0  1.08  0.8  2.64  <0.001  2.03  0.01
    (1.34–2.21)    (0.56–1.79)    (0.67–1.74)    (1.74–3.99)    (1.17–3.52)   
  1998–2002  1.84  <0.001  0.90  0.7  0.45  0.007  3.51  <0.001  1.84  0.03 
    (1.44–2.34)    (0.51–1.60)    (0.25–0.81)    (2.37–5.21)    (1.07–3.18)
  2003–2007  2.01  <0.001  0.36  0.009  0.20  <0.001  3.26  <0.001  3.85  <0.001
    (1.58–2.54)    (0.17–0.77)    (0.09–0.45)    (2.19–4.85)    (2.34–6.34)
After 1 year 
  1987–1992  1    1    1    1    1 
  1993–1997  0.87  <0.001  0.86  0.01  0.80  <0.001  1.29  0.04  1.01  1.0
    (0.81–0.94)    (0.77–0.97)    (0.74–0.87)    (1.02–1.64)    (0.76–1.32) 
  1998–2002  0.49  <0.001  0.62  <0.001  0.25  <0.001  1.53  0.001  0.91  0.5
    (0.45–0.54)    (0.54–0.73)    (0.21–0.28)    (1.18–1.99)    (0.68–1.21)
  2003–2007  0.52  <0.001  0.42  <0.001  0.17  <0.001  2.02  <0.001  1.23  0.2
    (0.44–0.60)    (0.31–0.58)    (0.13–0.23)    (1.44–2.81)    (0.88–1.71)
A–F, see Table 5a.Acta Orthopaedica 2010; 81 (6): 649–659  655
Table 5d. Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral com-
ponent, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). Other cemented prostheses, n = 58,704
  A  B  C  D  E  F
Total   
  1987–1992  1    1    1    1    1 
  1993–1997  0.83  <0.001  0.86  0.02  0.68  <0.001  1.50  0.002  1.15  0.4
    (0.76–0.90)    (0.75–0.97)    (0.61–0.75)    (1.17–1.94)    (0.84–1.58)
  1998–2002  0.60  <0.001  0.72  <0.001  0.27  <0.001  1.94  <0.001  1.17  0.3
    (0.55–0.66)    (0.61–0.85)    (0.24–0.32)    (1.51–2.51)    (0.86–1.60) 
  2003–2007  0.67  <0.001  0.41  <0.001  0.15  <0.001  2.08  <0.001  1.90  <0.001
    (0.59–0.76)    (0.30–0.56)    (0.11–0.20)    (1.58–2.73)    (1.40–2.57) 
First year 
  1987–1992  1    1    1    1    1 
  1993–1997  1.60  0.003  1.07  0.8  1.11  0.7  2.53  0.001  2.47  0.02
    (1.17–2.19)    (0.54–2.14)    (0.62–1.98)    (1.49–4.29)    (1.16–5.25) 
  1998–2002  1.79  <0.001  0.93  0.8  0.39  0.01  3.67  <0.001  2.09  0.05
    (1.34–2.40)    (0.47–1.81)    (0.19–0.81)    (2.25–5.99)    (0.99–4.40) 
  2003–2007  1.90  <0.001  0.36  0.02  0.20  <0.001  3.20  <0.001  4.78  <0.001  
    (1.43–2.50)    (0.16–0.84)    (0.08–0.49)    (1.97–5.20)    (2.46–9.31) 
After 1 year 
  1987–1992  1    1    1    1    1 
  1993–1997  0.79  <0.001  0.85  0.02  0.67  <0.001  1.26  0.1  0.96  0.8
    (0.73–0.86)    (0.75–0.97)    (0.60–0.74)    (0.94–1.69)    (0.67–1.36) 
  1998–2002  0.52  <0.001  0.71  <0.001  0.27  <0.001  1.41  0.04  1.03  0.9 
    (0.47–0.58)    (0.60–0.84)    (0.23–0.31)    (1.03–1.95)    (0.73–1.46) 
  2003–2007  0.48  <0.001  0.43  <0.001  0.14  <0.001  1.88  0.002  1.20  0.4
    (0.40–0.56)    (0.30–0.61)    (0.10–0.20)    (1.27–2.78)    (0.81–1.79) 
A–F, see Table 5a.
Table 5c. Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral 
component, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). Charnley prostheses with Palacos or Simplex 
cement, n = 28,225
  A  B  C  D  E  F
Total 
  1987–1992  1    1    1    1    1
  1993–1997  1.27  <0.001  1.12  0.3  1.28  0.001  1.75  0.002  1.15   0.5 
    (1.13–1.44)    (0.89–1.40)    (1.11–1.49)    (1.23–2.50)    (0.78–1.70) 
  1998–2002  0.61  <0.001  0.44  <0.001  0.21  <0.001  2.21  <0.001  0.88  0.6
    (0.51–0.72)    (0.30–0.63)    (0.15–0.28)    (1.54–3.18)    (0.58–1.35) 
  2003–2007  0.88  0.3  0.31  0.003  0.25  <0.001  2.61  <0.001  1.76  0.02
    (0.70–1.12)    (0.14–0.67)    (0.14–0.45)    (1.68–4.07)    (1.11–2.79) 
First year
  1987–1992  1    1    1    1    1 
  1993–1997  2.01  0.002  0.97  1.0  1.10  0.8  2.78  0.003  1.49  0.3
    (1.30–3.09)     (0.33–2.89)    (0.46–2.61)    (1.42–5.45)    (0.66–3.34) 
  1998–2002  2.00  0.002  0.91  0.9  0.61  0.3  3.30  <0.001  1.50 
    (1.23–3.07)     (0.31–2.72)    (0.23–1.63)    (1.71–6.39)    (0.68–3.35) 
  2003–2007  2.31  <0.001  0.24  0.2  0.17  0.09  3.63  <0.001  2.89  0.01
    (1.45–3.68)    (0.03–2.02)    (0.021.30)    (1.79–7.40)    (1.30–6.43) 
After 1 year 
  1987–1992  1    1    1    1    1 
  1993–1997  1.22  0.002  1.13  0.3  1.29  0.001  1.42  0.1  1.06  0. 8
    (1.07–1.39)    (0.89–1.42)    (1.11–1.50)    (0.93–2.17)    (0.68–1.66) 
  1998–2002  0.46  <0.001  0.39  <0.001  0.18  <0.001  1.83  0.008  0.70  0.2
    (0.38–0.56)    (0.26–0.58)    (0.13–0.26)    (1.17–2.87)    (0.41–1.17) 
  2003–2007  0.62  0.004  0.33  0.009  0.27  <0.001  2.36  0.009  1.34  0.3
    (0.45–0.86)    (0.14–0.76)    (0.15–0.48)    (1.24–4.50)    (0.74–2.45) 
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sis showed a reduction in overall revision with RR = 0.3 (95% 
CI: 0.25–0.35) when comparing the period 1998–2002 to the 
reference period (Table 5e, first column), also illustrated in 
Figure 3c. However, the overall revision rate as well as revi-
sion due to component loosening increased during the last 
study period (2003–2007) compared to 1998–2002 (Table 5e, 
columns 1–3). Furthermore, the risk of dislocation increased 
in this prosthesis group as well as for the cemented ones, par-
ticularly during the last study period (Table 5e, column 4) and 
the risk of revision due to infection increased markedly in the 
last study period (RR = 5.5 (95% CI: 2.9–11). 
The use of hybrid prostheses decreased in the latest time 
period while the opposite was seen for inverse hybrids (Table 
3). The survival curve for hybrids showed an improvement 
similar to that of other types, and even for the last time period, 
the development appeared to follow that of the previous time 
Table 5e. Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral com-
ponent, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). Uncemented prostheses, n = 14,621
  A  B  C  D  E  F
Total   
  1987–1992  1    1    1    1    1   
  1993–1997  0.61  <0.001  0.46  <0.001  0.16  <0.001  1.56  0.02  1.31  0.4
    (0.55–0.67)    (0.40–0.53)    (0.12–0.22)    (1.06–2.28)    (0.69–2.48) 
  1998–2002  0.30  <0.001  0.09  <0.001  0.11  <0.001  1.28  0.3  1.51  0.4
    (0.25–0.35)    (0.06–0.14)    (0.07–0.17)    (0.83–1.95)    (0.77–2.96)  0.2 
  2003–2007  0.91  0.4  0.28  <0.001  0.27  <0.001  1.93  0.005  5.51  <0.001
    (0.75–1.11)    (0.15–0.52)    (0.17–0.45)    (1.22.–3.05)    (2.85–10.66) 
First year 
  1987–1992  1    1    1    1    1 
  1993–1997  0.87  0.6  1.26  0.8  0.34  0.04  1.25  0.5  1.85  0.6
    (0.55–1.38)    (0.28–5.63)    (0.12–0.93)    (0.63–2.49)    (0.17–20.42) 
  1998–2002  1.04  0.9  0.59  0.6  0.19  0.01  1.15  0.7  6.00  0.09
    (0.67–1.61)    (0.10–3.53)    (0.06–0.67)    (0.58–2.28)    (0.74–48.81) 
  2003–2007  2.08  <0.001  1.41  0.6  0.75  0.5  1.68  0.1  18.07  0.005
    (1.41–3.05)    (0.34–5.90)    (0.35–1.64)    (0.89–3.16)    (2.43–134.2)   
After 1 year 
  1987–1992  1    1    1    1    1 
  1993–1997  0.60  <0.001  0.46  <0.001  0.15  <0.001  1.71  0.02  1.27  0.5
    (0.54–0.66)    (0.40–0.53)    (0.11–0.21)    (1.08–2.70)    (0.65–2.46) 
  1998–2002  0.25  <0.001  0.09  <0.001  0.11  <0.001  1.33  0.3  1.12  0.8
    (0.20–0.30)    (0.06–0.13)    (0.07–0.17)    (0.78–2.28)    (0.53–2.37) 
  2003–2007  0.62   0.001  0.18  <0.001  0.14  <0.001  2.11  0.04  3.77  0.001
    (0.47–0.83)    (0.08–0.42)    (0.07–0.31)    (1.04–2.27)    (1.70–8.38) 
A–F, see Table 5a.
Figure 4. Kaplan-Meier survival plot. Revision for any cause. A. 1987–2007. B. 1998–2007.
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period with more early revisions and fewer late ones, although 
a longer follow-up period would be needed to ascertain this 
(Figure 3d). 
Kaplan-Meier survival curves for every hospital performing 
hip arthroplasties in Norway during the 2 time periods 1987–
1997 and 1998–2007 showed a general improvement—lead-
ing to a narrower cluster of curves—with the mean survival 
for the latter time period being higher than for the first one 
(Figure 5).
Discussion
Our major finding was a general improvement in the results of 
hip replacement surgery during the 21-year period. This was 
seen for the total group as well as for all subgroups studied. 
Similar findings were reported from the Swedish Hip Reg-
istry (Herberts and Malchau 1997). However, in a recently 
published study on hip and knee arthroplasty in the USA per-
formed 1990–2002, Kurtz et al. (2005) found a constant revi-
sion rate during the study period. The positive development in 
Norway was due to a fall in revisions for aseptic loosening, a 
finding that has also been reported from the Swedish register 
(Herberts and Malchau 2000). 
An  important  cause  of  the  improvement  in  results  seen 
in our study can be attributed to the increasing use of well-
documented implants with good results. We believe that the 
publication of registry studies pointing out inferior implants 
and cements has played an important role in this develop-
ment.  For  example,  articles  from  the  NAR  concerning  the 
role of the cement type used for fixation were published in 
1995, 1997, and in 2002 (Havelin et al. 1995, Furnes et al. 
1997, Espehaug et al. 2002). In these studies, the superior-
ity of high-viscosity cements was documented and use of the 
inferior Boneloc cement ceased as a result, as did the use of 
CMW cements. The benefit of antibiotic-loaded cement and 
prophylactic systemic antibiotics was also demonstrated in 
studies from the registry (Espehaug et al. 1997, Engesaeter 
et al. 2003). Courses in cementation technique may also have 
contributed to this improvement. Furthermore, certain brands 
of uncemented acetabular and femoral components have been 
shown to be associated with an increased risk of loosening 
(Havelin et al. 1995, Havelin et al. 1995, 2002, Hallan et al. 
2007), which may have contributed to the improvement in the 
results of uncemented prostheses found in the period 1998–
2002. 
National  registries  provide  valuable  information  on  the 
epidemiology of specific diagnoses and/or treatments, treat-
ment results, and time changes in treatment and results. The 
Norwegian  Arthroplasty  Register  has  data  concerning  hip 
arthroplasty from 1987 to the present. Data from the regis-
ter is made public through annual reports, which are avail-
able on the internet (www.haukeland.no/nrl). These data thus 
represent performance measurements for hip arthroplasty in 
Norway, which is important to surgeons regarding the choice 
of implant type, fixation method, surgical access, and the use 
of antibiotics. Furthermore, such information may be of use to 
health policy makers in providing information on present and 
future demands (Kurtz et al. 2007), and also to the hospitals 
since results for each individual hospital (compared to all the 
others) are sent to all participating hospitals. 
The positive development in terms of a declining revision 
rate was, however, also seen in the rather homogenous sub-
group of Charnley implants inserted with Simplex or Pala-
cos cement, although the improvement was not seen until the 
third time period (1998–2002). This indicates that improve-
ment in surgical technique may also have played a part in the 
improvement in revision rate, which was indeed the intention 
Figure 5. Kaplan-Meier survival plot for cemented hip prostheses: every hospital in Norway 
in 2 time periods. A. 1987–1997. B. 1998–2008.658  Acta Orthopaedica 2010; 81 (6): 649–659
when obligatory training programs in prosthesis surgery were 
initiated for surgeons in 1995. The Norwegian company sell-
ing the Charnley prosthesis also initiated training programs 
for surgeons in 1995, emphasizing modern cementing tech-
nique and the same company introduced new instruments for 
improved prosthesis placement. 
In addition to the major finding of improved results during 
the 21-year study period, several other changes took place. 
The indication for inserting a hip implant changed, in that a 
gradual increase in the percentage of patients operated due to 
osteoarthritis was seen throughout the study period. Further-
more, the patients operated before 1993 were younger, which 
may, in part, be related to the first point. However, after 1993 
the  mean  age  remained  stable.  The  percentage  of  patients 
operated due to osteoarthritis increased, but the mean age in 
this patient group remained the same due to the acceptance of 
both older patients and younger patients for hip replacement 
surgery. A change in the timing of revision surgery took place, 
with more early and fewer late revisions in the latter time peri-
ods. This might reflect a change in failure types, with more 
revisions due to dislocation and early infections and fewer late 
revisions due to aseptic loosening. 
Another important trend was how the difference in results 
for the different hospitals diminished, giving a generally better 
hip arthroplasty service due to changes in the choice of implant 
brand, fixation method, and cement type. For instance, the use 
of inverse hybrid prostheses (with cementation of the acetabu-
lar component) increased, a method that gave better results 
than  uncemented  prostheses  and  the  regular  hybrids.  The 
changes in implant and cement types and brands may, in part, 
have resulted from published results from register studies. 
A newly published nationwide study from the USA has also 
found an increase over a 15-year period in the incidence of 
hip arthroplasties diagnosed with infection (Kurtz et al. 2008). 
However, a British study of about 6,000 hip arthroplasties 
reported no change in the rate of prosthetic joint infections 
(Phillips et al. 2006). We found an increase in revisions due 
to deep infection that was most pronounced for uncemented 
prostheses.  Hip  prosthesis  surgery  in  patients  with  more 
comorbidity, and more patients being on immunosuppressive 
drugs, may be plausible explanations for this development. 
For instance, obesity and diabetes are known risk factors for 
infection, and the incidences of both conditions are increas-
ing in the population. In addition, an increased awareness of 
low-virulence infections may have caused more surgeons to 
be aware of this problem. Consequently, some revision opera-
tions that would previously have been designated “revision 
due to aseptic loosening” are now correctly characterized as 
infections. Changes in treatment policy, as described by Dale 
et al. in a recently published study from our registry, may also 
have influenced the risk of prosthesis infection (Dale et al. 
2009). For example, an increase in patients with higher ASA 
score was seen during the most recent years of the study (this 
factor was registered in the NAR from 2005), and higher ASA 
scores adversely influenced the rate of infection. On the other 
hand, antibiotic-loaded bone cement protects against infection 
(Engesaeter et al. 2003, Dale et al. 2009) and the increasing 
use of antibiotic-loaded cement thus tended to reduce the risk 
of revision due to infection. 
In  the  large  American  study,  dislocation  was  the  most 
common  cause  of  revision  surgery  (Kurtz  et  al.  2008).  In 
Norway, loosening of prosthesis components was by far the 
most frequent cause of revision, but the risk of revision caused 
by dislocation increased. More revisions due to dislocation 
may result from more young patients having hip implants, as 
they are more active. Increasing use of small femoral heads 
on modular prostheses has been shown to be associated with 
an increased risk of revision due to dislocation (Bystrom et 
al. 2003, Berry et al. 2005). In the study by Bystrom et al. 
on data from the NAR, the use of 28-mm heads in the later 
period, compared to 32-mm heads previously, was found to 
be the main cause of the increase in revisions due to disloca-
tion. From 2006, the use of 32-mm, 36-mm, and even larger 
head sizes has increased in both older and younger patients, 
in combination with the use of new bearing surfaces such as 
highly crosslinked polyethylene. Hopefully, this will contrib-
ute to a reduction in revisions due to dislocation in the future. 
Furthermore, the surgical approach has been shown to influ-
ence the risk of dislocation (Berry et al. 2005, Arthursson et 
al. 2007). In the article by Arthursson et al. from Norway, the 
change from a lateral approach with trochanteric osteotomy to 
a lateral approach without trochanteric osteotomy contributed 
to the increase in dislocation rate for Charnley prostheses. 
Possible changes in treatment policy based on these findings 
might, in time, lead to a decline in the rate of revisions due to 
dislocation.
In conclusion, from 1987 through 2007, the revision rate 
after hip arthroplasty surgery decreased. The best results were 
obtained with the use of cemented prostheses, but the results 
of uncemented prostheses also improved throughout the study 
period. A change in the revision pattern took place, with more 
early revisions and less late revisions performed. There was an 
increase in revisions due to dislocation and infection.
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